Longitudinal Validation of the Cutaneous Lupus Erythematosus Quality of Life Index
This study evaluated the Cutaneous Lupus Erythematosus (CLE) Quality of Life index (CLEQoL) as a valid, accurate, and longitudinally responsive patient reported outcome measure amongst CLE patients. Results show that the CLEQoL accurately captures QoL impacts amongst CLE patients and tracks changes in QoL impacts across time and disease activity.
Authors
- Benjamin F. Chong (ORCID: https://orcid.org/0000-0002-4092-7658)
- Victoria P. Werth (ORCID: https://orcid.org/0000-0003-3030-5369)
- Motolani E. Ogunsanya (ORCID: https://orcid.org/0000-0002-4005-0446)
- Vraj K Shah
- Elena Wei (ORCID: https://orcid.org/0000-0003-2885-0659)
- Stephen Neely
Institutions
- Oklahoma City University (US)
- University of Oklahoma Health Sciences Center (US)
- University of Pennsylvania (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2026-09-30
- DOI
- https://doi.org/10.1093/bjd/ljag432
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00